194 related articles for article (PubMed ID: 36082153)
1. Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-Cancer.
Xu Y; Shen M; Peng Y; Liu L; Tang L; Yang T; Pu D; Tan W; Zhang W; Liu S
Biomed Res Int; 2022; 2022():4632453. PubMed ID: 36082153
[TBL] [Abstract][Full Text] [Related]
2. CDCA3 Is a Novel Prognostic Biomarker Associated with Immune Infiltration in Hepatocellular Carcinoma.
Wang Z; Chen S; Wang G; Li S; Qin X
Biomed Res Int; 2021; 2021():6622437. PubMed ID: 33604380
[TBL] [Abstract][Full Text] [Related]
3. CDCA3 is a potential prognostic marker that promotes cell proliferation in gastric cancer.
Zhang Y; Yin W; Cao W; Chen P; Bian L; Ni Q
Oncol Rep; 2019 Apr; 41(4):2471-2481. PubMed ID: 30816466
[TBL] [Abstract][Full Text] [Related]
4. CDCA3 mediates p21-dependent proliferation by regulating E2F1 expression in colorectal cancer.
Qian W; Zhang Z; Peng W; Li J; Gu Q; Ji D; Wang Q; Zhang Y; Ji B; Wang S; Zhang D; Sun Y
Int J Oncol; 2018 Nov; 53(5):2021-2033. PubMed ID: 30226575
[TBL] [Abstract][Full Text] [Related]
5. Translating bioinformatics in oncology: guilt-by-profiling analysis and identification of KIF18B and CDCA3 as novel driver genes in carcinogenesis.
Itzel T; Scholz P; Maass T; Krupp M; Marquardt JU; Strand S; Becker D; Staib F; Binder H; Roessler S; Wang XW; Thorgeirsson S; Müller M; Galle PR; Teufel A
Bioinformatics; 2015 Jan; 31(2):216-24. PubMed ID: 25236463
[TBL] [Abstract][Full Text] [Related]
6. Pan-cancer analysis identifies
Yang H; Wei X; Zhang L; Xiang L; Wang P
Transl Cancer Res; 2022 Aug; 11(8):2902-2916. PubMed ID: 36093552
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of CDCA3 in kidney renal papillary cell carcinoma.
Li H; Li M; Yang C; Guo F; Deng S; Li L; Ma T; Yan J; Wu H; Li X
Aging (Albany NY); 2021 Dec; 13(23):25466-25483. PubMed ID: 34905505
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive pan-cancer analysis reveals NUSAP1 is a novel predictive biomarker for prognosis and immunotherapy response.
Zheng H; Wang M; Zhang S; Hu D; Yang Q; Chen M; Zhang X; Zhang Y; Dai J; Liou YC
Int J Biol Sci; 2023; 19(14):4689-4708. PubMed ID: 37781040
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of cell cycle regulator CDCA3 promotes oral cancer progression by enhancing cell proliferation with prevention of G1 phase arrest.
Uchida F; Uzawa K; Kasamatsu A; Takatori H; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Bukawa H
BMC Cancer; 2012 Jul; 12():321. PubMed ID: 22839099
[TBL] [Abstract][Full Text] [Related]
10. CDCA3 is a potential biomarker for glioma malignancy and targeted therapy.
Han C; Liu S; Ji Y; Hu Y; Zhang J
Medicine (Baltimore); 2024 May; 103(19):e38066. PubMed ID: 38728485
[TBL] [Abstract][Full Text] [Related]
11. RUNX1 is a promising prognostic biomarker and related to immune infiltrates of cancer-associated fibroblasts in human cancers.
Tuo Z; Zhang Y; Wang X; Dai S; Liu K; Xia D; Wang J; Bi L
BMC Cancer; 2022 May; 22(1):523. PubMed ID: 35534796
[TBL] [Abstract][Full Text] [Related]
12. Expression of CDCA3 Is a Prognostic Biomarker and Potential Therapeutic Target in Non-Small Cell Lung Cancer.
Adams MN; Burgess JT; He Y; Gately K; Snell C; Zhang SD; Hooper JD; Richard DJ; O'Byrne KJ
J Thorac Oncol; 2017 Jul; 12(7):1071-1084. PubMed ID: 28487093
[TBL] [Abstract][Full Text] [Related]
13. Suppression of CDCA3 inhibits prostate cancer progression via NF‑κB/cyclin D1 signaling inactivation and p21 accumulation.
Gu P; Zhang M; Zhu J; He X; Yang D
Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34970697
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of cell division cycle-associated protein-3 in prostate cancer.
Gu P; Zhang M; Chen X; Du J; Chen L; He X; Li M
Medicine (Baltimore); 2023 Sep; 102(36):e34655. PubMed ID: 37682152
[TBL] [Abstract][Full Text] [Related]
15. LncCDCA3L inhibits cell proliferation via a novel RNA structure-based crosstalk with CDCA3 in hepatocellular carcinoma.
Wang Y; Liu Y; Zhang T; Guan G; Mao T; Liu H; Zhang J; Lu F; Chen X
Liver Int; 2022 Jun; 42(6):1432-1446. PubMed ID: 35230745
[TBL] [Abstract][Full Text] [Related]
16. HoxB3 promotes prostate cancer cell progression by transactivating CDCA3.
Chen J; Zhu S; Jiang N; Shang Z; Quan C; Niu Y
Cancer Lett; 2013 Apr; 330(2):217-24. PubMed ID: 23219899
[TBL] [Abstract][Full Text] [Related]
17. Integrate analysis of the promote function of Cell division cycle-associated protein family to pancreatic adenocarcinoma.
Xing C; Wang Z; Zhu Y; Zhang C; Liu M; Hu X; Chen W; Du Y
Int J Med Sci; 2021; 18(3):672-684. PubMed ID: 33437202
[No Abstract] [Full Text] [Related]
18. CDCA3 Predicts Poor Prognosis and Affects CD8
Bai Y; Liao S; Yin Z; You B; Lu D; Chen Y; Chen D; Wu Y
J Oncol; 2022; 2022():6343760. PubMed ID: 36213833
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA ST8SIA6-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by targeting miR-145-5p/CDCA3 to inactivate the p53/p21 signaling pathway.
Qiao Y; Wang B; Yan Y; Niu L
Environ Toxicol; 2022 Oct; 37(10):2398-2411. PubMed ID: 35730485
[TBL] [Abstract][Full Text] [Related]
20. CDCA3 promotes cell proliferation by activating the NF-κB/cyclin D1 signaling pathway in colorectal cancer.
Zhang W; Lu Y; Li X; Zhang J; Zheng L; Zhang W; Lin C; Lin W; Li X
Biochem Biophys Res Commun; 2018 Jun; 500(2):196-203. PubMed ID: 29627567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
